Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Navidea Biopharmaceuticals Inc (NYSE American:NAVB)

0.4375
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
0.29
Today|||52-Week Range
0.85
-31.37%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues3.4M580.0K611.6K223.7K
 
 
 
 
 
Cost of Goods Sold242.3K0.000.000.00
 
 
Depreciation And Amortization122.5K86.5K70.5K50.3K
 
 
 
 
 
 
Operating ExpensesGross Income3.0M493.5K541.1K173.3K
 
 
 
 
 
General Expenses5.4M3.6M4.3M2.5M
 
 
 
 
 
Research And Development2.4M705.3K1.2M874.5K
 
 
 
 
 
Total Operating Expenses5.8M3.7M4.3M2.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.4M-3.1M-3.7M-2.4M
 
 
 
 
 
Extraordinary Credit1.1M140.5K12.9K0.00
 
 
 
 
Extraordinary Charge0.00-1.3M-394.0K-35.0K
 
 
 
 
Interest Expense On Debt2.6M0.000.000.00
 
 
Other Expenses22.0K-21.6K-722.7K-7.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.9M-4.3M-4.8M-2.3M
 
 
 
 
 
Income Taxes0.00-1.5M-1.6M-775.8K
 
 
 
 
Minority Interest-132.00-202.00-33.00-23.00
 
 
 
 
 
Discontinued Operations0.00-255.9K-82.4K5.4K
 
 
 
 
Extraordinary Items0.0088.7M-2.0M145.9K
 
 
 
 
Net Income-3.9M-3.1M-3.2M-1.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS155.5M160.4M161.9M162.0M
 
 
 
 
 
Shares To Calculate EPS Diluted155.5M164.9M161.9M162.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.02$0.52-$0.03-$0.01
 
 
 
 
 
EPS Diluted-$0.02-$0.02-$0.02-$0.01